policies >  DOI:10.25504/FAIRsharing.d8fvz
FAIRsharing is in read-only mode until September while we migrate our data to our new, improved system. In the meantime, please read our blog post or get in touch with us if you need to edit or add records, or have any questions.

ready Elsevier - Lancet Oncology - Information for Authors


General Information

Homepage https://www.thelancet.com/lanonc/about

Countries that developed this resource China , United Kingdom , United States

Published in 2000

Type: Journal

Description:

The Information for Authors page contains a broad range of guidelines for publishing in Lancet Oncology. With regards to data deposition, novel gene sequences should be deposited in a public database (GenBank, EMBL, or DDBJ), and the accession number provided. Authors of microarray papers should include in their submission the information recommended by the MIAME guidelines. Authors should also submit their experimental details to one of the publicly available databases: ArrayExpress or GEO.

Taxonomic range



How to cite this record FAIRsharing.org: Elsevier - Lancet Oncology - Information for Authors; DOI: https://doi.org/10.25504/FAIRsharing.d8fvz; Last edited: Feb. 18, 2020, 5:39 p.m.; Last accessed: Jul 28 2021 8:30 a.m.


This record is maintained by msoareses  ORCID

Record added: June 2, 2016, 11:16 a.m. Record updated: Feb. 18, 2020, 5:35 p.m. by The FAIRsharing Team.
Show edit history


Organisations

Record Maintainer

Maintains


Policy External Cross References

TOP Level Data Transparency: 0: Not TOP compliant

TOP qualifying comments: Data disclosure is required for clinical trials, but "For reports of research other than clinical trials, data sharing statements are encouraged but not required."




Usage / Access

Support

General

Additional Information